Our passion for immuno-oncology is relentless

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.

Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire our relentless research and development in advancing treatments. Our mission is to change the cancer treatment paradigm and make a difference in patient lives every day.


Eugene P. Kennedy, MD
Chief Medical Officer

Carl Langren
Chief Financial Officer